Philippa Marrack
Concepts (887)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
T-Lymphocytes | 225 | 2021 | 1774 | 9.250 |
Why?
| Receptors, Antigen, T-Cell, alpha-beta | 62 | 2019 | 310 | 5.460 |
Why?
| Receptors, Antigen, T-Cell | 112 | 2021 | 632 | 5.270 |
Why?
| Lymphocyte Activation | 74 | 2020 | 1067 | 4.850 |
Why?
| B-Lymphocytes | 65 | 2018 | 770 | 4.510 |
Why?
| Histocompatibility Antigens Class II | 73 | 2021 | 355 | 4.110 |
Why?
| Thymus Gland | 59 | 2019 | 300 | 4.060 |
Why?
| CD4-Positive T-Lymphocytes | 40 | 2021 | 984 | 3.920 |
Why?
| Adjuvants, Immunologic | 14 | 2017 | 207 | 3.860 |
Why?
| Autoimmunity | 17 | 2023 | 831 | 3.830 |
Why?
| Major Histocompatibility Complex | 57 | 2021 | 220 | 3.790 |
Why?
| CD8-Positive T-Lymphocytes | 22 | 2021 | 702 | 3.270 |
Why?
| Immunologic Memory | 27 | 2020 | 313 | 3.220 |
Why?
| Histocompatibility Antigens | 18 | 2019 | 102 | 2.950 |
Why?
| Mice | 314 | 2021 | 15520 | 2.780 |
Why?
| Animals | 358 | 2021 | 33381 | 2.510 |
Why?
| T-Lymphocyte Subsets | 22 | 2018 | 396 | 2.250 |
Why?
| B-Lymphocyte Subsets | 8 | 2020 | 66 | 2.200 |
Why?
| Peptides | 42 | 2021 | 879 | 2.150 |
Why?
| Alum Compounds | 7 | 2017 | 22 | 2.080 |
Why?
| Antigens | 38 | 2020 | 320 | 2.070 |
Why?
| Proto-Oncogene Proteins | 13 | 2009 | 618 | 2.000 |
Why?
| Mice, Inbred C57BL | 103 | 2020 | 4908 | 1.810 |
Why?
| Immune Tolerance | 30 | 2021 | 334 | 1.800 |
Why?
| Apoptosis | 17 | 2018 | 2484 | 1.800 |
Why?
| Toll-Like Receptor 7 | 5 | 2016 | 35 | 1.680 |
Why?
| T-Box Domain Proteins | 7 | 2020 | 95 | 1.660 |
Why?
| Dendritic Cells | 11 | 2017 | 442 | 1.650 |
Why?
| Hybridomas | 73 | 2019 | 233 | 1.610 |
Why?
| Apoptosis Regulatory Proteins | 11 | 2011 | 190 | 1.570 |
Why?
| Enterotoxins | 26 | 2009 | 86 | 1.560 |
Why?
| Aging | 11 | 2018 | 1670 | 1.470 |
Why?
| Membrane Proteins | 12 | 2020 | 1055 | 1.350 |
Why?
| Superantigens | 20 | 2019 | 68 | 1.330 |
Why?
| Antigen-Presenting Cells | 21 | 2015 | 156 | 1.320 |
Why?
| Mice, Transgenic | 43 | 2018 | 2025 | 1.300 |
Why?
| Autoantigens | 17 | 2021 | 397 | 1.290 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 12 | 2007 | 226 | 1.290 |
Why?
| H-2 Antigens | 38 | 2011 | 111 | 1.280 |
Why?
| CD11c Antigen | 5 | 2020 | 38 | 1.260 |
Why?
| Autoimmune Diseases | 10 | 2021 | 398 | 1.260 |
Why?
| Antigen Presentation | 15 | 2017 | 194 | 1.130 |
Why?
| Antigens, Surface | 24 | 2011 | 156 | 1.120 |
Why?
| Immunity, Cellular | 15 | 2010 | 270 | 1.110 |
Why?
| Peptide Fragments | 18 | 2021 | 702 | 1.100 |
Why?
| Spleen | 27 | 2016 | 510 | 1.100 |
Why?
| Amino Acid Sequence | 65 | 2019 | 2071 | 1.090 |
Why?
| Vaccines | 4 | 2017 | 380 | 1.090 |
Why?
| Herpesviridae Infections | 3 | 2017 | 142 | 1.060 |
Why?
| Immune System | 7 | 2013 | 181 | 1.060 |
Why?
| Protein Binding | 31 | 2021 | 1975 | 1.050 |
Why?
| Berylliosis | 5 | 2020 | 183 | 1.050 |
Why?
| Autoantibodies | 7 | 2023 | 1335 | 1.020 |
Why?
| Mammary Tumor Virus, Mouse | 12 | 1995 | 41 | 1.000 |
Why?
| Interleukin-2 | 38 | 2015 | 416 | 1.000 |
Why?
| Interleukin-12 | 2 | 2016 | 110 | 1.000 |
Why?
| Epitopes | 46 | 2021 | 443 | 0.980 |
Why?
| Signal Transduction | 21 | 2018 | 4709 | 0.980 |
Why?
| Antigens, Viral | 10 | 2001 | 181 | 0.980 |
Why?
| Clone Cells | 18 | 2008 | 248 | 0.970 |
Why?
| Interferon-gamma | 13 | 2016 | 736 | 0.950 |
Why?
| Gene Expression Regulation | 21 | 2015 | 2445 | 0.920 |
Why?
| Molecular Sequence Data | 60 | 2015 | 2871 | 0.920 |
Why?
| Immunoglobulin G | 8 | 2017 | 788 | 0.840 |
Why?
| Cytokines | 16 | 2020 | 1900 | 0.810 |
Why?
| Sarcoidosis, Pulmonary | 2 | 2020 | 56 | 0.810 |
Why?
| Cell Differentiation | 31 | 2018 | 1753 | 0.770 |
Why?
| Antibody Formation | 19 | 2017 | 276 | 0.740 |
Why?
| Flow Cytometry | 26 | 2015 | 1085 | 0.730 |
Why?
| Carrier Proteins | 11 | 2009 | 726 | 0.730 |
Why?
| Aluminum | 2 | 2010 | 34 | 0.720 |
Why?
| Alveolitis, Extrinsic Allergic | 1 | 2020 | 83 | 0.720 |
Why?
| Genes, MHC Class II | 19 | 2014 | 72 | 0.720 |
Why?
| Mice, Inbred BALB C | 48 | 2021 | 1206 | 0.710 |
Why?
| Lymphocytes | 5 | 2018 | 347 | 0.710 |
Why?
| Cell Survival | 17 | 2009 | 1047 | 0.710 |
Why?
| Alleles | 12 | 2017 | 832 | 0.700 |
Why?
| Mice, Knockout | 20 | 2017 | 2680 | 0.690 |
Why?
| Obsessive-Compulsive Disorder | 1 | 2019 | 44 | 0.690 |
Why?
| Cell Death | 15 | 2019 | 339 | 0.680 |
Why?
| Ovalbumin | 22 | 2011 | 165 | 0.680 |
Why?
| bcl-2-Associated X Protein | 5 | 2006 | 46 | 0.680 |
Why?
| Mice, Inbred Strains | 36 | 2000 | 405 | 0.670 |
Why?
| Natural Killer T-Cells | 6 | 2018 | 62 | 0.660 |
Why?
| Bronchoalveolar Lavage Fluid | 2 | 2020 | 613 | 0.650 |
Why?
| Antibodies, Monoclonal | 52 | 2016 | 1284 | 0.650 |
Why?
| CD8 Antigens | 10 | 2013 | 71 | 0.650 |
Why?
| Lupus Erythematosus, Systemic | 3 | 2017 | 227 | 0.640 |
Why?
| Enzyme-Linked Immunosorbent Assay | 9 | 2017 | 827 | 0.640 |
Why?
| Thymocytes | 3 | 2018 | 29 | 0.640 |
Why?
| Cells, Cultured | 27 | 2019 | 4077 | 0.620 |
Why?
| Interleukin-15 | 6 | 2013 | 77 | 0.610 |
Why?
| Disease Susceptibility | 1 | 2019 | 331 | 0.610 |
Why?
| Interleukin-4 | 6 | 2008 | 215 | 0.610 |
Why?
| Interleukin-7 | 4 | 2004 | 44 | 0.610 |
Why?
| Herpesviridae | 1 | 2017 | 20 | 0.610 |
Why?
| Amino Acids | 5 | 2022 | 465 | 0.610 |
Why?
| Cat Diseases | 1 | 2017 | 15 | 0.610 |
Why?
| Epitopes, T-Lymphocyte | 6 | 2021 | 170 | 0.600 |
Why?
| Humans | 122 | 2023 | 118974 | 0.590 |
Why?
| Cell Line | 41 | 2021 | 2707 | 0.580 |
Why?
| Bcl-2-Like Protein 11 | 9 | 2009 | 38 | 0.580 |
Why?
| Membrane Glycoproteins | 6 | 2013 | 446 | 0.580 |
Why?
| Deoxyribonucleases | 1 | 2016 | 21 | 0.570 |
Why?
| Friend murine leukemia virus | 1 | 2016 | 30 | 0.570 |
Why?
| Homeostasis | 5 | 2007 | 594 | 0.570 |
Why?
| Cell Proliferation | 12 | 2020 | 2275 | 0.570 |
Why?
| Ikaros Transcription Factor | 2 | 2013 | 17 | 0.560 |
Why?
| Antigens, Neoplasm | 4 | 2021 | 228 | 0.550 |
Why?
| Complementarity Determining Regions | 6 | 2011 | 45 | 0.550 |
Why?
| Models, Molecular | 25 | 2018 | 1435 | 0.540 |
Why?
| Influenza A virus | 2 | 2013 | 90 | 0.530 |
Why?
| Reactive Oxygen Species | 3 | 2003 | 576 | 0.530 |
Why?
| Antigens, Bacterial | 8 | 2013 | 116 | 0.520 |
Why?
| Staphylococcus aureus | 12 | 1999 | 394 | 0.510 |
Why?
| Evolution, Molecular | 4 | 2019 | 454 | 0.510 |
Why?
| Histocompatibility Antigens Class I | 10 | 2013 | 177 | 0.510 |
Why?
| Histone Demethylases | 3 | 2020 | 28 | 0.500 |
Why?
| Immunity, Innate | 6 | 2019 | 745 | 0.500 |
Why?
| Cell Division | 10 | 2008 | 776 | 0.500 |
Why?
| Viral Proteins | 2 | 2009 | 296 | 0.470 |
Why?
| Models, Immunological | 8 | 2017 | 94 | 0.460 |
Why?
| Clonal Deletion | 4 | 2004 | 18 | 0.460 |
Why?
| Protein Conformation | 19 | 2018 | 848 | 0.460 |
Why?
| Nucleoproteins | 1 | 2013 | 28 | 0.460 |
Why?
| Gammaherpesvirinae | 1 | 2013 | 39 | 0.460 |
Why?
| T-Lymphocytes, Cytotoxic | 5 | 2012 | 158 | 0.450 |
Why?
| Th2 Cells | 3 | 2010 | 164 | 0.450 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2013 | 71 | 0.450 |
Why?
| Mutation | 22 | 2022 | 3457 | 0.440 |
Why?
| Hypersensitivity | 2 | 2014 | 268 | 0.440 |
Why?
| DNA | 10 | 2016 | 1388 | 0.430 |
Why?
| Lymphocyte Cooperation | 22 | 2006 | 50 | 0.430 |
Why?
| Spike Glycoprotein, Coronavirus | 3 | 2022 | 94 | 0.430 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 3 | 2013 | 34 | 0.420 |
Why?
| Base Sequence | 33 | 2015 | 2159 | 0.420 |
Why?
| Female | 65 | 2021 | 61565 | 0.410 |
Why?
| bcl-X Protein | 4 | 2006 | 41 | 0.410 |
Why?
| Staphylococcus | 5 | 1994 | 68 | 0.410 |
Why?
| Clonal Anergy | 3 | 2006 | 54 | 0.400 |
Why?
| Antibodies | 7 | 2009 | 392 | 0.400 |
Why?
| Receptors, Cell Surface | 4 | 2020 | 367 | 0.400 |
Why?
| Receptors, Chemokine | 2 | 2008 | 45 | 0.400 |
Why?
| Binding Sites | 19 | 2021 | 1224 | 0.400 |
Why?
| Receptors, CXCR5 | 1 | 2011 | 11 | 0.400 |
Why?
| Lipid A | 1 | 2011 | 28 | 0.390 |
Why?
| Chromosomes, Human, X | 2 | 2015 | 58 | 0.390 |
Why?
| Vaccines, Subunit | 1 | 2011 | 42 | 0.390 |
Why?
| Mast Cells | 2 | 2009 | 115 | 0.390 |
Why?
| Th1 Cells | 2 | 2010 | 133 | 0.390 |
Why?
| Inflammation | 5 | 2020 | 2566 | 0.380 |
Why?
| Germ Cells | 2 | 2016 | 64 | 0.370 |
Why?
| Minor Lymphocyte Stimulatory Antigens | 11 | 1993 | 22 | 0.360 |
Why?
| Cell Communication | 9 | 2013 | 281 | 0.360 |
Why?
| Nobel Prize | 1 | 2009 | 4 | 0.360 |
Why?
| Genes | 16 | 1990 | 231 | 0.360 |
Why?
| Gonadal Steroid Hormones | 2 | 2014 | 122 | 0.360 |
Why?
| Antigens, Differentiation, T-Lymphocyte | 17 | 1991 | 83 | 0.360 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 2 | 2006 | 15 | 0.360 |
Why?
| Genetics, Medical | 1 | 2009 | 26 | 0.350 |
Why?
| Protein Processing, Post-Translational | 7 | 2018 | 408 | 0.350 |
Why?
| Glycoproteins | 3 | 2011 | 319 | 0.350 |
Why?
| T-Cell Antigen Receptor Specificity | 3 | 2011 | 41 | 0.350 |
Why?
| Macrophages, Peritoneal | 1 | 2009 | 96 | 0.350 |
Why?
| Receptors, Immunologic | 3 | 2020 | 209 | 0.330 |
Why?
| HLA-DR Antigens | 8 | 2008 | 224 | 0.330 |
Why?
| Cytotoxicity, Immunologic | 7 | 2009 | 204 | 0.330 |
Why?
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 770 | 0.330 |
Why?
| Herpesvirus 4, Human | 1 | 2009 | 126 | 0.330 |
Why?
| Cell Movement | 7 | 2017 | 896 | 0.330 |
Why?
| Vaccination | 4 | 2010 | 1222 | 0.320 |
Why?
| Binding, Competitive | 8 | 2003 | 205 | 0.320 |
Why?
| Transcription Factors | 5 | 2012 | 1570 | 0.310 |
Why?
| Allergy and Immunology | 2 | 2006 | 57 | 0.310 |
Why?
| CD3 Complex | 8 | 2009 | 92 | 0.300 |
Why?
| Receptors, Interleukin-2 | 4 | 2003 | 65 | 0.300 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 2 | 2018 | 59 | 0.300 |
Why?
| Bone Marrow Cells | 5 | 2016 | 273 | 0.300 |
Why?
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 4 | 2012 | 26 | 0.300 |
Why?
| HLA-DP beta-Chains | 4 | 2014 | 78 | 0.290 |
Why?
| Diabetes Mellitus, Type 1 | 8 | 2021 | 3360 | 0.290 |
Why?
| Genetic Predisposition to Disease | 4 | 2010 | 2275 | 0.290 |
Why?
| Gene Expression Profiling | 6 | 2018 | 1597 | 0.280 |
Why?
| Histones | 3 | 2018 | 552 | 0.280 |
Why?
| Inflammation Mediators | 1 | 2009 | 502 | 0.280 |
Why?
| T-Lymphocytes, Helper-Inducer | 10 | 1989 | 130 | 0.280 |
Why?
| Transfection | 16 | 2008 | 888 | 0.270 |
Why?
| History, 20th Century | 6 | 2016 | 281 | 0.270 |
Why?
| Bacterial Toxins | 6 | 1997 | 106 | 0.270 |
Why?
| Lipopolysaccharides | 10 | 2005 | 870 | 0.270 |
Why?
| Lymph Nodes | 13 | 2015 | 455 | 0.270 |
Why?
| Antigens, CD1d | 5 | 2013 | 63 | 0.260 |
Why?
| Insulin | 4 | 2019 | 2162 | 0.260 |
Why?
| Mitochondria | 4 | 2008 | 786 | 0.260 |
Why?
| RNA, Messenger | 10 | 2022 | 2657 | 0.250 |
Why?
| Cell Membrane | 6 | 2004 | 710 | 0.250 |
Why?
| Repressor Proteins | 2 | 2015 | 377 | 0.250 |
Why?
| Protein Folding | 1 | 2006 | 250 | 0.250 |
Why?
| Immunoglobulin Variable Region | 11 | 2012 | 71 | 0.250 |
Why?
| Baculoviridae | 7 | 2015 | 46 | 0.250 |
Why?
| Histiocytosis, Non-Langerhans-Cell | 1 | 2004 | 5 | 0.250 |
Why?
| Beryllium | 3 | 2014 | 151 | 0.250 |
Why?
| Gene Expression | 10 | 2017 | 1489 | 0.240 |
Why?
| Interleukin-6 | 3 | 2011 | 688 | 0.240 |
Why?
| Neoplasms, Experimental | 3 | 2021 | 158 | 0.240 |
Why?
| Lymphokines | 13 | 1984 | 122 | 0.240 |
Why?
| Cell Separation | 12 | 2008 | 296 | 0.240 |
Why?
| Gene Rearrangement, T-Lymphocyte | 2 | 2001 | 13 | 0.230 |
Why?
| Positive Transcriptional Elongation Factor B | 2 | 2020 | 22 | 0.230 |
Why?
| Crystallography, X-Ray | 9 | 2018 | 422 | 0.230 |
Why?
| Lysosomes | 2 | 2021 | 136 | 0.230 |
Why?
| Genes, bcl-2 | 1 | 2002 | 20 | 0.220 |
Why?
| Chromogranin A | 2 | 2015 | 40 | 0.220 |
Why?
| beta 2-Microglobulin | 4 | 2010 | 47 | 0.220 |
Why?
| Oligopeptides | 2 | 2001 | 252 | 0.220 |
Why?
| Ubiquitin-Protein Ligases | 3 | 2008 | 148 | 0.220 |
Why?
| Antibodies, Monoclonal, Humanized | 3 | 2022 | 667 | 0.220 |
Why?
| Radiation Chimera | 4 | 2001 | 31 | 0.210 |
Why?
| Cloning, Molecular | 13 | 2017 | 546 | 0.210 |
Why?
| T-Lymphocytes, Regulatory | 5 | 2017 | 359 | 0.210 |
Why?
| Egg Proteins | 1 | 2001 | 19 | 0.210 |
Why?
| Concanavalin A | 17 | 1990 | 74 | 0.210 |
Why?
| Cross Reactions | 7 | 2012 | 116 | 0.210 |
Why?
| Cell Culture Techniques | 2 | 2001 | 356 | 0.210 |
Why?
| Ligands | 9 | 2022 | 567 | 0.210 |
Why?
| NF-kappa B | 2 | 2017 | 670 | 0.210 |
Why?
| Transcription, Genetic | 7 | 2020 | 1323 | 0.210 |
Why?
| Polymorphism, Genetic | 6 | 2012 | 642 | 0.210 |
Why?
| Moloney murine leukemia virus | 1 | 2001 | 11 | 0.210 |
Why?
| Mice, Mutant Strains | 7 | 2008 | 280 | 0.210 |
Why?
| Cytochrome c Group | 4 | 1997 | 37 | 0.200 |
Why?
| Lung Diseases | 2 | 2010 | 718 | 0.200 |
Why?
| Open Reading Frames | 3 | 1992 | 121 | 0.200 |
Why?
| Interferon-alpha | 4 | 2014 | 191 | 0.200 |
Why?
| Transduction, Genetic | 1 | 2001 | 116 | 0.200 |
Why?
| Receptors, Fc | 2 | 2020 | 48 | 0.200 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1992 | 103 | 0.200 |
Why?
| Cathepsins | 1 | 2021 | 22 | 0.200 |
Why?
| Immunoglobulin Idiotypes | 7 | 1986 | 20 | 0.200 |
Why?
| B7-1 Antigen | 3 | 2004 | 69 | 0.200 |
Why?
| HLA-C Antigens | 1 | 2021 | 32 | 0.200 |
Why?
| Macromolecular Substances | 16 | 2003 | 201 | 0.200 |
Why?
| Chimera | 8 | 2009 | 60 | 0.190 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 394 | 0.190 |
Why?
| Tumor Necrosis Factor-alpha | 4 | 2006 | 1171 | 0.190 |
Why?
| Genetic Vectors | 2 | 2001 | 302 | 0.190 |
Why?
| Immunity | 3 | 2007 | 129 | 0.190 |
Why?
| Self Tolerance | 3 | 2017 | 28 | 0.190 |
Why?
| Immunity, Humoral | 2 | 2022 | 117 | 0.190 |
Why?
| RNA Polymerase II | 2 | 2020 | 282 | 0.190 |
Why?
| Hematopoietic Stem Cells | 4 | 2014 | 359 | 0.190 |
Why?
| Cyclin-Dependent Kinase 9 | 1 | 2020 | 9 | 0.190 |
Why?
| HLA-DQ Antigens | 2 | 2019 | 176 | 0.190 |
Why?
| Sex Characteristics | 3 | 2015 | 671 | 0.190 |
Why?
| Protein Structure, Tertiary | 7 | 2021 | 823 | 0.190 |
Why?
| Interferon-beta | 3 | 2007 | 82 | 0.190 |
Why?
| Disease Models, Animal | 6 | 2014 | 3730 | 0.190 |
Why?
| Mice, Inbred NOD | 7 | 2019 | 574 | 0.180 |
Why?
| Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 237 | 0.180 |
Why?
| Transcription Factor AP-1 | 1 | 2000 | 81 | 0.180 |
Why?
| Lymphocytic choriomeningitis virus | 2 | 2011 | 20 | 0.180 |
Why?
| Kidney | 2 | 2017 | 1353 | 0.180 |
Why?
| Receptors, Complement 3d | 1 | 2020 | 129 | 0.180 |
Why?
| Genome | 2 | 2000 | 277 | 0.180 |
Why?
| Male | 30 | 2020 | 57801 | 0.180 |
Why?
| Methyltransferases | 1 | 2020 | 61 | 0.180 |
Why?
| Peptide Library | 4 | 2013 | 80 | 0.170 |
Why?
| Vaccinia | 1 | 1999 | 19 | 0.170 |
Why?
| CD28 Antigens | 2 | 2008 | 46 | 0.170 |
Why?
| Case-Control Studies | 2 | 2020 | 3171 | 0.170 |
Why?
| Neoplasms | 3 | 2021 | 2179 | 0.170 |
Why?
| Macrophages | 17 | 1988 | 1324 | 0.170 |
Why?
| fas Receptor | 4 | 2002 | 98 | 0.170 |
Why?
| Caspase 1 | 2 | 2009 | 143 | 0.170 |
Why?
| Lymphocyte Count | 4 | 2010 | 136 | 0.170 |
Why?
| Adaptive Immunity | 2 | 2017 | 161 | 0.170 |
Why?
| Trans-Activators | 2 | 2000 | 373 | 0.160 |
Why?
| Mass Spectrometry | 3 | 2020 | 681 | 0.160 |
Why?
| Germinal Center | 2 | 2017 | 47 | 0.160 |
Why?
| Immunotherapy | 3 | 2021 | 493 | 0.160 |
Why?
| Nickel | 2 | 2012 | 53 | 0.160 |
Why?
| Antigens, CD | 4 | 2000 | 460 | 0.160 |
Why?
| Dose-Response Relationship, Immunologic | 11 | 2000 | 82 | 0.160 |
Why?
| Crosses, Genetic | 6 | 2006 | 138 | 0.160 |
Why?
| Adoptive Transfer | 6 | 2015 | 204 | 0.160 |
Why?
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2009 | 150 | 0.160 |
Why?
| Complement C3b Inactivator Proteins | 1 | 2017 | 9 | 0.160 |
Why?
| Interferon Type I | 1 | 1999 | 129 | 0.160 |
Why?
| Minor Histocompatibility Antigens | 2 | 2015 | 41 | 0.160 |
Why?
| Receptors, Interferon | 2 | 2013 | 49 | 0.160 |
Why?
| Time Factors | 10 | 2013 | 6412 | 0.150 |
Why?
| CD4 Antigens | 9 | 1998 | 126 | 0.150 |
Why?
| Retinal Pigment Epithelium | 1 | 2017 | 60 | 0.150 |
Why?
| Mice, Inbred DBA | 18 | 2001 | 174 | 0.150 |
Why?
| Complement Factor H | 1 | 2017 | 61 | 0.150 |
Why?
| Receptors, IgE | 1 | 1997 | 40 | 0.150 |
Why?
| Cats | 1 | 2017 | 205 | 0.150 |
Why?
| Substrate Specificity | 1 | 2017 | 371 | 0.150 |
Why?
| Mice, Inbred C3H | 8 | 1993 | 250 | 0.140 |
Why?
| Complement Pathway, Alternative | 1 | 2017 | 117 | 0.140 |
Why?
| Blotting, Western | 3 | 2020 | 1194 | 0.140 |
Why?
| Phenotype | 9 | 2008 | 3003 | 0.140 |
Why?
| Drug Contamination | 1 | 2016 | 54 | 0.140 |
Why?
| Lupus Nephritis | 4 | 2012 | 55 | 0.140 |
Why?
| Myeloid Differentiation Factor 88 | 1 | 2016 | 95 | 0.140 |
Why?
| Immunoconjugates | 1 | 1997 | 89 | 0.140 |
Why?
| HLA Antigens | 3 | 2013 | 230 | 0.140 |
Why?
| Graft Rejection | 3 | 2015 | 555 | 0.140 |
Why?
| Hematopoiesis | 1 | 1997 | 175 | 0.140 |
Why?
| Chemokine CCL19 | 1 | 2015 | 6 | 0.130 |
Why?
| Chemokine CCL21 | 1 | 2015 | 13 | 0.130 |
Why?
| Serum Albumin, Bovine | 5 | 2011 | 67 | 0.130 |
Why?
| Receptors, CCR7 | 1 | 2015 | 24 | 0.130 |
Why?
| Imidazoles | 1 | 2016 | 232 | 0.130 |
Why?
| Down-Regulation | 3 | 2003 | 627 | 0.130 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 1 | 2015 | 82 | 0.130 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2015 | 40 | 0.130 |
Why?
| Antiviral Agents | 1 | 2021 | 654 | 0.130 |
Why?
| Skin Transplantation | 1 | 2015 | 58 | 0.130 |
Why?
| Immunization | 8 | 2013 | 412 | 0.130 |
Why?
| Nicotine | 1 | 2017 | 276 | 0.130 |
Why?
| Sequence Homology, Nucleic Acid | 7 | 1992 | 155 | 0.130 |
Why?
| Thymoma | 4 | 2012 | 31 | 0.130 |
Why?
| Amino Acid Motifs | 5 | 2019 | 200 | 0.130 |
Why?
| Immunoglobulin Heavy Chains | 6 | 1988 | 72 | 0.120 |
Why?
| Mycobacterium tuberculosis | 1 | 2017 | 266 | 0.120 |
Why?
| Epithelium | 6 | 1997 | 305 | 0.120 |
Why?
| Macrophages, Alveolar | 1 | 2017 | 359 | 0.120 |
Why?
| Green Fluorescent Proteins | 3 | 2013 | 395 | 0.120 |
Why?
| Granuloma | 1 | 2014 | 87 | 0.120 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2006 | 982 | 0.120 |
Why?
| Hybridization, Genetic | 2 | 2014 | 79 | 0.120 |
Why?
| Molecular Weight | 11 | 2006 | 343 | 0.120 |
Why?
| Antibodies, Viral | 1 | 2017 | 542 | 0.120 |
Why?
| Organ Culture Techniques | 6 | 1993 | 149 | 0.120 |
Why?
| DNA Mutational Analysis | 2 | 2009 | 381 | 0.120 |
Why?
| Receptors, Interleukin-7 | 2 | 2006 | 26 | 0.120 |
Why?
| Fluorescent Antibody Technique | 4 | 2004 | 410 | 0.120 |
Why?
| Heparin-binding EGF-like Growth Factor | 1 | 2013 | 11 | 0.110 |
Why?
| Conserved Sequence | 3 | 2009 | 219 | 0.110 |
Why?
| Lymphocytes, Null | 1 | 2012 | 2 | 0.110 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 369 | 0.110 |
Why?
| HLA-DR4 Antigen | 2 | 2005 | 75 | 0.110 |
Why?
| Kinetics | 13 | 2021 | 1624 | 0.110 |
Why?
| Minor Histocompatibility Loci | 2 | 1990 | 4 | 0.110 |
Why?
| Killer Cells, Natural | 2 | 2007 | 381 | 0.110 |
Why?
| Diphtheria Toxin | 1 | 2013 | 63 | 0.110 |
Why?
| Age Factors | 4 | 2017 | 2995 | 0.110 |
Why?
| Escherichia coli | 4 | 2013 | 758 | 0.110 |
Why?
| Mice, Nude | 3 | 2013 | 663 | 0.110 |
Why?
| Cell Lineage | 2 | 2013 | 318 | 0.110 |
Why?
| Genes, Immunoglobulin | 3 | 1988 | 26 | 0.110 |
Why?
| Hemocyanins | 8 | 1983 | 57 | 0.110 |
Why?
| Immunophenotyping | 3 | 2004 | 278 | 0.110 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 333 | 0.110 |
Why?
| Rhadinovirus | 1 | 2012 | 16 | 0.110 |
Why?
| DNA Primers | 1 | 2013 | 533 | 0.110 |
Why?
| Galactosylceramides | 2 | 2012 | 22 | 0.110 |
Why?
| Tumor Virus Infections | 1 | 2012 | 41 | 0.110 |
Why?
| Haplotypes | 4 | 1990 | 473 | 0.110 |
Why?
| Burkitt Lymphoma | 1 | 2012 | 53 | 0.100 |
Why?
| Communicable Diseases | 1 | 1994 | 132 | 0.100 |
Why?
| Virus Diseases | 2 | 1992 | 198 | 0.100 |
Why?
| Mice, Inbred CBA | 8 | 1991 | 59 | 0.100 |
Why?
| Dermatitis, Allergic Contact | 1 | 2012 | 60 | 0.100 |
Why?
| Ubiquitination | 2 | 2008 | 87 | 0.100 |
Why?
| Nucleocapsid Proteins | 1 | 2011 | 24 | 0.100 |
Why?
| Viral Core Proteins | 1 | 2011 | 21 | 0.100 |
Why?
| Immunologic Deficiency Syndromes | 3 | 2007 | 75 | 0.100 |
Why?
| Resting Phase, Cell Cycle | 1 | 2011 | 15 | 0.100 |
Why?
| Receptors, Lymphocyte Homing | 1 | 2011 | 16 | 0.100 |
Why?
| Surface Plasmon Resonance | 3 | 2021 | 85 | 0.100 |
Why?
| Orthomyxoviridae Infections | 1 | 2011 | 53 | 0.100 |
Why?
| Salts | 1 | 2010 | 39 | 0.100 |
Why?
| Cell Line, Tumor | 4 | 2021 | 2851 | 0.100 |
Why?
| Bone Marrow | 2 | 2009 | 255 | 0.090 |
Why?
| Electrophoresis, Polyacrylamide Gel | 7 | 2011 | 332 | 0.090 |
Why?
| Tumor Necrosis Factor Ligand Superfamily Member 15 | 1 | 2010 | 8 | 0.090 |
Why?
| Structure-Activity Relationship | 8 | 2006 | 522 | 0.090 |
Why?
| Fibrin | 1 | 2010 | 60 | 0.090 |
Why?
| Antibody Specificity | 7 | 1997 | 184 | 0.090 |
Why?
| HLA-DP Antigens | 1 | 2010 | 33 | 0.090 |
Why?
| Immunoprecipitation | 2 | 2008 | 161 | 0.090 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2015 | 814 | 0.090 |
Why?
| Lymphocyte Function-Associated Antigen-1 | 6 | 1999 | 35 | 0.090 |
Why?
| Antibodies, Neutralizing | 2 | 2022 | 228 | 0.090 |
Why?
| Recombinant Proteins | 7 | 2005 | 1308 | 0.090 |
Why?
| Antigen-Antibody Reactions | 6 | 2021 | 51 | 0.090 |
Why?
| Molecular Docking Simulation | 2 | 2021 | 101 | 0.090 |
Why?
| Cattle | 2 | 2011 | 978 | 0.090 |
Why?
| France | 1 | 2009 | 35 | 0.090 |
Why?
| Fibrinogen | 1 | 2010 | 161 | 0.090 |
Why?
| Thrombin | 1 | 2010 | 143 | 0.090 |
Why?
| Injections, Intraperitoneal | 1 | 2009 | 108 | 0.090 |
Why?
| Retroviridae | 2 | 2013 | 89 | 0.090 |
Why?
| Aluminum Compounds | 1 | 2009 | 7 | 0.090 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2009 | 17 | 0.090 |
Why?
| Immunoglobulin Class Switching | 1 | 2009 | 15 | 0.090 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2011 | 197 | 0.090 |
Why?
| Phosphorylation | 4 | 2020 | 1633 | 0.090 |
Why?
| Antioxidants | 2 | 2003 | 564 | 0.090 |
Why?
| Aged, 80 and over | 1 | 2020 | 6561 | 0.090 |
Why?
| Biomarkers | 1 | 2019 | 3588 | 0.090 |
Why?
| Antibody Affinity | 3 | 2005 | 55 | 0.080 |
Why?
| Integrin alpha4 | 1 | 2008 | 7 | 0.080 |
Why?
| Cell Adhesion Molecules | 1 | 1990 | 180 | 0.080 |
Why?
| Proto-Oncogene Proteins c-cbl | 1 | 2008 | 12 | 0.080 |
Why?
| Lymphocytic Choriomeningitis | 1 | 2008 | 12 | 0.080 |
Why?
| History, 21st Century | 1 | 2009 | 170 | 0.080 |
Why?
| Adsorption | 1 | 2009 | 129 | 0.080 |
Why?
| Aged | 3 | 2020 | 19657 | 0.080 |
Why?
| Sequence Homology, Amino Acid | 3 | 2004 | 372 | 0.080 |
Why?
| Protein Domains | 2 | 2020 | 212 | 0.080 |
Why?
| Chondroitin | 1 | 1988 | 5 | 0.080 |
Why?
| Genes, Switch | 1 | 1988 | 7 | 0.080 |
Why?
| Genes, Regulator | 1 | 1988 | 33 | 0.080 |
Why?
| Cytoskeletal Proteins | 1 | 2009 | 146 | 0.080 |
Why?
| Antigens, Helminth | 1 | 2008 | 15 | 0.080 |
Why?
| Immunoglobulin Isotypes | 1 | 2008 | 32 | 0.080 |
Why?
| Biosensing Techniques | 1 | 2009 | 107 | 0.080 |
Why?
| Methylation | 3 | 2018 | 204 | 0.080 |
Why?
| Histocompatibility Antigen H-2D | 3 | 2010 | 21 | 0.080 |
Why?
| Schistosoma mansoni | 1 | 2008 | 39 | 0.080 |
Why?
| Influenza Vaccines | 1 | 2013 | 500 | 0.080 |
Why?
| Chondroitin Sulfates | 1 | 1988 | 35 | 0.080 |
Why?
| Genetic Linkage | 7 | 1989 | 321 | 0.080 |
Why?
| Polymerase Chain Reaction | 6 | 1997 | 1012 | 0.080 |
Why?
| Species Specificity | 9 | 2006 | 565 | 0.080 |
Why?
| Mice, Inbred AKR | 10 | 1989 | 34 | 0.080 |
Why?
| RNA-Binding Proteins | 1 | 2011 | 371 | 0.080 |
Why?
| Transplantation Chimera | 3 | 2014 | 51 | 0.080 |
Why?
| Receptor, Interferon alpha-beta | 1 | 2007 | 22 | 0.080 |
Why?
| Hybrid Cells | 4 | 1997 | 46 | 0.080 |
Why?
| Pancreas | 2 | 2021 | 282 | 0.080 |
Why?
| Infection Control | 1 | 2009 | 135 | 0.080 |
Why?
| Erythrocytes | 15 | 1983 | 641 | 0.080 |
Why?
| Fluoresceins | 2 | 2004 | 47 | 0.080 |
Why?
| Moths | 3 | 1997 | 36 | 0.080 |
Why?
| Arthritis, Rheumatoid | 3 | 2005 | 989 | 0.080 |
Why?
| Immunoglobulin Fab Fragments | 2 | 2006 | 69 | 0.070 |
Why?
| Dose-Response Relationship, Drug | 2 | 2003 | 1945 | 0.070 |
Why?
| In Vitro Techniques | 8 | 2000 | 1094 | 0.070 |
Why?
| Early Growth Response Protein 2 | 2 | 2018 | 11 | 0.070 |
Why?
| Poly I-C | 1 | 2006 | 55 | 0.070 |
Why?
| Health | 1 | 2007 | 81 | 0.070 |
Why?
| Arginine | 2 | 2018 | 249 | 0.070 |
Why?
| B-Cell Activating Factor | 1 | 2006 | 18 | 0.070 |
Why?
| Hyaluronan Receptors | 3 | 2003 | 93 | 0.070 |
Why?
| Chemokines | 1 | 2007 | 230 | 0.070 |
Why?
| Chemotaxis, Leukocyte | 2 | 2003 | 133 | 0.070 |
Why?
| Leukopoiesis | 1 | 2006 | 10 | 0.070 |
Why?
| Transgenes | 2 | 1997 | 174 | 0.070 |
Why?
| Spodoptera | 2 | 2021 | 37 | 0.070 |
Why?
| Tissue Distribution | 3 | 1993 | 334 | 0.070 |
Why?
| Peptide Hydrolases | 1 | 2006 | 108 | 0.070 |
Why?
| Promoter Regions, Genetic | 4 | 2020 | 1158 | 0.070 |
Why?
| Cell Fusion | 4 | 1989 | 51 | 0.070 |
Why?
| Insulin-Secreting Cells | 1 | 2010 | 330 | 0.070 |
Why?
| Caspases | 2 | 2014 | 269 | 0.070 |
Why?
| Protein Structure, Secondary | 4 | 2012 | 338 | 0.070 |
Why?
| HLA-D Antigens | 2 | 1998 | 36 | 0.070 |
Why?
| Recombinant Fusion Proteins | 4 | 2001 | 653 | 0.070 |
Why?
| Sheep | 11 | 1983 | 764 | 0.070 |
Why?
| Prostaglandins E | 1 | 1985 | 47 | 0.070 |
Why?
| Leukemia P388 | 2 | 1984 | 7 | 0.060 |
Why?
| Proteolysis | 2 | 2018 | 146 | 0.060 |
Why?
| Enzyme Activation | 3 | 2008 | 828 | 0.060 |
Why?
| Succinimides | 1 | 2004 | 17 | 0.060 |
Why?
| Young Adult | 1 | 2020 | 10793 | 0.060 |
Why?
| Whole-Body Irradiation | 2 | 2013 | 72 | 0.060 |
Why?
| Immunoglobulin Allotypes | 1 | 1984 | 6 | 0.060 |
Why?
| MAP Kinase Kinase Kinases | 2 | 2008 | 71 | 0.060 |
Why?
| Phosphatidylserines | 1 | 2005 | 91 | 0.060 |
Why?
| Plasmids | 4 | 2001 | 355 | 0.060 |
Why?
| Fibroblasts | 3 | 2017 | 842 | 0.060 |
Why?
| Sex Factors | 1 | 2010 | 1781 | 0.060 |
Why?
| B-Cell CLL-Lymphoma 10 Protein | 1 | 2004 | 2 | 0.060 |
Why?
| DNA, Complementary | 1 | 2004 | 268 | 0.060 |
Why?
| Phosphoserine | 1 | 2004 | 34 | 0.060 |
Why?
| Fetus | 4 | 2014 | 690 | 0.060 |
Why?
| Lung | 4 | 2014 | 3664 | 0.060 |
Why?
| Antigens, Differentiation | 2 | 1997 | 79 | 0.060 |
Why?
| Leukemia, Experimental | 1 | 1983 | 27 | 0.060 |
Why?
| Receptors, Leukotriene B4 | 1 | 2003 | 10 | 0.060 |
Why?
| Leukotriene B4 | 1 | 2003 | 51 | 0.060 |
Why?
| Catalase | 1 | 2003 | 123 | 0.060 |
Why?
| Luminescent Proteins | 2 | 2001 | 174 | 0.060 |
Why?
| Chromosome Mapping | 6 | 1989 | 510 | 0.060 |
Why?
| Chromosome Deletion | 4 | 1991 | 95 | 0.060 |
Why?
| RNA | 3 | 2003 | 833 | 0.060 |
Why?
| Bone Marrow Transplantation | 3 | 2014 | 244 | 0.060 |
Why?
| Incidence | 1 | 2010 | 2424 | 0.060 |
Why?
| Antibody-Producing Cells | 7 | 1983 | 29 | 0.060 |
Why?
| Protein Biosynthesis | 3 | 1992 | 397 | 0.060 |
Why?
| Selection, Genetic | 2 | 2019 | 252 | 0.060 |
Why?
| Myeloid Cells | 1 | 2004 | 128 | 0.060 |
Why?
| Fas Ligand Protein | 1 | 2003 | 60 | 0.060 |
Why?
| Binding Sites, Antibody | 5 | 1991 | 38 | 0.060 |
Why?
| Solubility | 4 | 1998 | 235 | 0.060 |
Why?
| Fluorescent Dyes | 2 | 2001 | 316 | 0.050 |
Why?
| Antigens, Ly | 4 | 1988 | 45 | 0.050 |
Why?
| Interleukin-1 | 5 | 1997 | 980 | 0.050 |
Why?
| Vaccines, Synthetic | 1 | 2022 | 128 | 0.050 |
Why?
| Lymphocyte Depletion | 3 | 1992 | 119 | 0.050 |
Why?
| Mesencephalon | 1 | 2002 | 57 | 0.050 |
Why?
| Synovial Fluid | 2 | 2000 | 56 | 0.050 |
Why?
| Sequence Alignment | 2 | 2008 | 336 | 0.050 |
Why?
| Receptors, Tumor Necrosis Factor | 1 | 2002 | 147 | 0.050 |
Why?
| Sf9 Cells | 1 | 2021 | 9 | 0.050 |
Why?
| Saccharomyces cerevisiae | 1 | 2005 | 495 | 0.050 |
Why?
| Tumor Cells, Cultured | 3 | 2000 | 874 | 0.050 |
Why?
| Chronic Disease | 3 | 2013 | 1636 | 0.050 |
Why?
| Sex Chromosome Aberrations | 1 | 1981 | 53 | 0.050 |
Why?
| Interphase | 2 | 2000 | 30 | 0.050 |
Why?
| Transplantation, Heterologous | 1 | 2002 | 194 | 0.050 |
Why?
| Crystallization | 2 | 2015 | 146 | 0.050 |
Why?
| Vaccinia virus | 1 | 2001 | 34 | 0.050 |
Why?
| Hemolytic Plaque Technique | 10 | 1983 | 30 | 0.050 |
Why?
| Calcium | 6 | 2004 | 1169 | 0.050 |
Why?
| Growth Inhibitors | 1 | 2001 | 43 | 0.050 |
Why?
| Borrelia burgdorferi Group | 1 | 2000 | 8 | 0.050 |
Why?
| Middle Aged | 2 | 2020 | 27617 | 0.050 |
Why?
| Temperature | 1 | 2003 | 622 | 0.050 |
Why?
| Receptors, Virus | 1 | 2021 | 78 | 0.050 |
Why?
| Immunosuppressive Agents | 1 | 2005 | 681 | 0.050 |
Why?
| Receptors, Interleukin-15 | 1 | 2000 | 3 | 0.050 |
Why?
| Nucleic Acid Hybridization | 2 | 1999 | 193 | 0.050 |
Why?
| Antibody Diversity | 3 | 1989 | 17 | 0.050 |
Why?
| Phorbol Esters | 1 | 2000 | 16 | 0.050 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2000 | 11 | 0.050 |
Why?
| Lymphocyte Culture Test, Mixed | 3 | 1990 | 46 | 0.050 |
Why?
| Expressed Sequence Tags | 1 | 2000 | 38 | 0.050 |
Why?
| Specific Pathogen-Free Organisms | 1 | 2000 | 61 | 0.050 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2000 | 19 | 0.050 |
Why?
| Up-Regulation | 1 | 2003 | 872 | 0.050 |
Why?
| Haploidy | 1 | 1980 | 21 | 0.050 |
Why?
| Adult | 3 | 2020 | 31512 | 0.050 |
Why?
| Receptors, Interleukin-6 | 1 | 2000 | 36 | 0.050 |
Why?
| Cancer Vaccines | 1 | 2021 | 139 | 0.050 |
Why?
| Protein Interaction Domains and Motifs | 1 | 2021 | 138 | 0.050 |
Why?
| Jurkat Cells | 1 | 2000 | 134 | 0.050 |
Why?
| STAT1 Transcription Factor | 1 | 2000 | 69 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2000 | 100 | 0.050 |
Why?
| Cell Line, Transformed | 1 | 2000 | 136 | 0.040 |
Why?
| Lipoproteins | 1 | 2000 | 162 | 0.040 |
Why?
| Gene Knockout Techniques | 1 | 2020 | 105 | 0.040 |
Why?
| Lymphocyte Transfusion | 1 | 1999 | 19 | 0.040 |
Why?
| DNA-Binding Proteins | 2 | 2012 | 1346 | 0.040 |
Why?
| Leukemia L1210 | 1 | 1999 | 7 | 0.040 |
Why?
| Haptens | 3 | 1988 | 22 | 0.040 |
Why?
| Rats | 5 | 2002 | 5392 | 0.040 |
Why?
| Lymphopenia | 1 | 1999 | 48 | 0.040 |
Why?
| Recombination, Genetic | 4 | 1988 | 173 | 0.040 |
Why?
| Peer Review, Research | 1 | 1999 | 35 | 0.040 |
Why?
| Free Radical Scavengers | 1 | 1999 | 88 | 0.040 |
Why?
| Manganese | 1 | 1999 | 55 | 0.040 |
Why?
| Chickens | 5 | 1994 | 185 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 1999 | 115 | 0.040 |
Why?
| Cholic Acids | 1 | 1998 | 17 | 0.040 |
Why?
| HIV Envelope Protein gp120 | 1 | 1999 | 60 | 0.040 |
Why?
| DNA Repair | 1 | 2020 | 198 | 0.040 |
Why?
| Cell Cycle | 2 | 2020 | 550 | 0.040 |
Why?
| Detergents | 1 | 1998 | 44 | 0.040 |
Why?
| Coculture Techniques | 2 | 2013 | 208 | 0.040 |
Why?
| Metalloporphyrins | 1 | 1999 | 103 | 0.040 |
Why?
| Nucleosomes | 1 | 2020 | 131 | 0.040 |
Why?
| Hot Temperature | 2 | 2000 | 334 | 0.040 |
Why?
| Trinitrobenzenes | 5 | 1982 | 13 | 0.040 |
Why?
| Membrane Potentials | 1 | 1999 | 253 | 0.040 |
Why?
| Oligodeoxyribonucleotides | 2 | 2005 | 139 | 0.040 |
Why?
| Behavior, Animal | 1 | 2002 | 486 | 0.040 |
Why?
| STAT3 Transcription Factor | 1 | 2000 | 189 | 0.040 |
Why?
| Lymphoma | 5 | 1985 | 180 | 0.040 |
Why?
| Crystallography | 2 | 2007 | 25 | 0.040 |
Why?
| Mice, Inbred A | 6 | 1984 | 45 | 0.040 |
Why?
| Neutrophils | 1 | 2004 | 1233 | 0.040 |
Why?
| NFATC Transcription Factors | 1 | 2018 | 82 | 0.040 |
Why?
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1998 | 102 | 0.040 |
Why?
| Host-Pathogen Interactions | 1 | 2021 | 300 | 0.040 |
Why?
| Autophagosomes | 1 | 2017 | 21 | 0.040 |
Why?
| Nicotinic Antagonists | 1 | 2017 | 19 | 0.040 |
Why?
| Recovery of Function | 1 | 2002 | 604 | 0.040 |
Why?
| Endocytosis | 1 | 1998 | 156 | 0.040 |
Why?
| MAP Kinase Signaling System | 1 | 1999 | 292 | 0.040 |
Why?
| STAT6 Transcription Factor | 1 | 1997 | 22 | 0.040 |
Why?
| Parkinson Disease | 1 | 2002 | 334 | 0.040 |
Why?
| Mutagenesis | 2 | 2013 | 176 | 0.040 |
Why?
| Dinoprostone | 2 | 1991 | 193 | 0.040 |
Why?
| Abatacept | 1 | 1997 | 42 | 0.040 |
Why?
| Columbidae | 2 | 1994 | 31 | 0.040 |
Why?
| Societies, Medical | 1 | 2001 | 703 | 0.040 |
Why?
| Oligonucleotides | 2 | 2004 | 140 | 0.040 |
Why?
| Receptors, Complement | 1 | 2017 | 115 | 0.040 |
Why?
| Phylogeny | 1 | 2021 | 816 | 0.040 |
Why?
| Gene Transfer Techniques | 1 | 1998 | 154 | 0.040 |
Why?
| Interleukins | 1 | 1999 | 242 | 0.040 |
Why?
| Immunomodulation | 1 | 2017 | 89 | 0.040 |
Why?
| CTLA-4 Antigen | 1 | 1997 | 86 | 0.040 |
Why?
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2017 | 50 | 0.040 |
Why?
| Amino Acid Substitution | 1 | 1997 | 276 | 0.040 |
Why?
| Respiratory Hypersensitivity | 1 | 1997 | 65 | 0.040 |
Why?
| Germ-Line Mutation | 2 | 2009 | 134 | 0.040 |
Why?
| Hemolysis | 1 | 2017 | 174 | 0.040 |
Why?
| Gene Deletion | 2 | 2009 | 361 | 0.040 |
Why?
| Protein Subunits | 1 | 2017 | 211 | 0.040 |
Why?
| Genetic Complementation Test | 2 | 1986 | 62 | 0.040 |
Why?
| Immunity, Mucosal | 1 | 1997 | 86 | 0.030 |
Why?
| Molecular Conformation | 2 | 2009 | 146 | 0.030 |
Why?
| Sequence Homology | 1 | 1995 | 40 | 0.030 |
Why?
| Nitrophenols | 4 | 2004 | 31 | 0.030 |
Why?
| Hydrogen-Ion Concentration | 3 | 2003 | 536 | 0.030 |
Why?
| Liposomes | 2 | 2005 | 151 | 0.030 |
Why?
| Models, Biological | 2 | 1993 | 1715 | 0.030 |
Why?
| Epitope Mapping | 2 | 2011 | 49 | 0.030 |
Why?
| Molecular Structure | 2 | 2003 | 459 | 0.030 |
Why?
| Immunoglobulins | 2 | 1987 | 154 | 0.030 |
Why?
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 2012 | 21 | 0.030 |
Why?
| Histocompatibility Testing | 1 | 2015 | 123 | 0.030 |
Why?
| Receptors, Nicotinic | 1 | 2017 | 295 | 0.030 |
Why?
| gamma-Globulins | 4 | 1983 | 19 | 0.030 |
Why?
| Antilymphocyte Serum | 8 | 1981 | 66 | 0.030 |
Why?
| Insecta | 2 | 2006 | 68 | 0.030 |
Why?
| Databases, Factual | 1 | 2000 | 1231 | 0.030 |
Why?
| Protein Transport | 2 | 2008 | 412 | 0.030 |
Why?
| Immunoglobulin E | 2 | 1997 | 365 | 0.030 |
Why?
| V(D)J Recombination | 1 | 2014 | 4 | 0.030 |
Why?
| Peptide Biosynthesis | 1 | 1994 | 14 | 0.030 |
Why?
| Enzyme-Linked Immunospot Assay | 1 | 2014 | 33 | 0.030 |
Why?
| JNK Mitogen-Activated Protein Kinases | 2 | 2008 | 155 | 0.030 |
Why?
| Cysteine | 2 | 2010 | 184 | 0.030 |
Why?
| Molecular Targeted Therapy | 1 | 2017 | 356 | 0.030 |
Why?
| Gene Dosage | 1 | 2014 | 136 | 0.030 |
Why?
| Cell Adhesion | 3 | 1999 | 443 | 0.030 |
Why?
| CD4-CD8 Ratio | 1 | 1993 | 19 | 0.030 |
Why?
| Horses | 4 | 1981 | 106 | 0.030 |
Why?
| Transferrin | 1 | 1993 | 39 | 0.030 |
Why?
| Disulfides | 2 | 1984 | 91 | 0.030 |
Why?
| Transplantation, Homologous | 1 | 2015 | 415 | 0.030 |
Why?
| Transplantation Immunology | 1 | 1993 | 31 | 0.030 |
Why?
| United States | 3 | 2015 | 12555 | 0.030 |
Why?
| Autophagy | 1 | 2017 | 315 | 0.030 |
Why?
| Cell Transplantation | 1 | 1993 | 39 | 0.030 |
Why?
| Mutagenesis, Site-Directed | 2 | 2011 | 363 | 0.030 |
Why?
| Multigene Family | 2 | 1991 | 200 | 0.030 |
Why?
| Trypsin | 4 | 2006 | 72 | 0.030 |
Why?
| Hydrogen Bonding | 2 | 2008 | 146 | 0.030 |
Why?
| Sodium | 1 | 2014 | 200 | 0.030 |
Why?
| Viral Envelope Proteins | 1 | 1994 | 80 | 0.030 |
Why?
| Endopeptidase K | 1 | 2013 | 14 | 0.030 |
Why?
| Epigenesis, Genetic | 1 | 2017 | 539 | 0.030 |
Why?
| Forkhead Transcription Factors | 1 | 2014 | 182 | 0.030 |
Why?
| Blotting, Southern | 1 | 1993 | 67 | 0.030 |
Why?
| Growth Substances | 2 | 1983 | 136 | 0.030 |
Why?
| Interleukin-2 Receptor beta Subunit | 1 | 2013 | 20 | 0.030 |
Why?
| Fetal Tissue Transplantation | 1 | 1992 | 35 | 0.030 |
Why?
| HLA-DR Serological Subtypes | 1 | 2012 | 4 | 0.030 |
Why?
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2012 | 24 | 0.030 |
Why?
| Vomiting | 1 | 1993 | 123 | 0.030 |
Why?
| Hepatocytes | 1 | 2014 | 205 | 0.030 |
Why?
| Mice, Inbred MRL lpr | 1 | 2012 | 39 | 0.030 |
Why?
| Chromosomal Proteins, Non-Histone | 1 | 2012 | 103 | 0.030 |
Why?
| DNA Methylation | 1 | 1996 | 503 | 0.030 |
Why?
| Intestinal Mucosa | 1 | 1997 | 531 | 0.030 |
Why?
| Embryonic and Fetal Development | 1 | 1992 | 95 | 0.030 |
Why?
| Perissodactyla | 4 | 1981 | 12 | 0.030 |
Why?
| Neoplasm Transplantation | 1 | 2012 | 245 | 0.030 |
Why?
| Disease | 1 | 1993 | 98 | 0.030 |
Why?
| Immunoassay | 2 | 1989 | 101 | 0.030 |
Why?
| Ionomycin | 1 | 1991 | 24 | 0.030 |
Why?
| Immunotherapy, Adoptive | 1 | 1993 | 191 | 0.030 |
Why?
| Cellular Senescence | 1 | 1993 | 151 | 0.030 |
Why?
| DNA, Recombinant | 3 | 2005 | 42 | 0.030 |
Why?
| Oligonucleotides, Antisense | 1 | 1992 | 100 | 0.030 |
Why?
| Tetradecanoylphorbol Acetate | 1 | 1991 | 155 | 0.030 |
Why?
| Tumor Burden | 1 | 2012 | 274 | 0.030 |
Why?
| Receptors, Natural Killer Cell | 1 | 2011 | 16 | 0.020 |
Why?
| Mice, Inbred NZB | 2 | 2007 | 17 | 0.020 |
Why?
| Glycosylation | 4 | 1994 | 129 | 0.020 |
Why?
| Blotting, Northern | 1 | 1991 | 194 | 0.020 |
Why?
| Genotype | 1 | 1996 | 1882 | 0.020 |
Why?
| Analysis of Variance | 1 | 2014 | 1293 | 0.020 |
Why?
| Pregnancy | 2 | 2014 | 5691 | 0.020 |
Why?
| Lysine | 1 | 2012 | 248 | 0.020 |
Why?
| Mutant Chimeric Proteins | 1 | 2010 | 4 | 0.020 |
Why?
| DNA, Bacterial | 1 | 1992 | 314 | 0.020 |
Why?
| Receptors, Leukocyte-Adhesion | 1 | 1990 | 5 | 0.020 |
Why?
| Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 1990 | 5 | 0.020 |
Why?
| Depression, Chemical | 1 | 1990 | 23 | 0.020 |
Why?
| RNA Splicing | 1 | 1991 | 243 | 0.020 |
Why?
| Oligonucleotide Probes | 1 | 1990 | 53 | 0.020 |
Why?
| HLA-A Antigens | 1 | 2010 | 50 | 0.020 |
Why?
| Milk | 1 | 1991 | 125 | 0.020 |
Why?
| Epoprostenol | 1 | 1991 | 132 | 0.020 |
Why?
| Amidohydrolases | 1 | 1990 | 29 | 0.020 |
Why?
| Restriction Mapping | 3 | 1998 | 76 | 0.020 |
Why?
| Smoking | 1 | 2017 | 1487 | 0.020 |
Why?
| Histidine | 2 | 2003 | 63 | 0.020 |
Why?
| Multiprotein Complexes | 1 | 2011 | 149 | 0.020 |
Why?
| Lipid Metabolism | 1 | 2013 | 477 | 0.020 |
Why?
| Precipitin Tests | 2 | 1991 | 93 | 0.020 |
Why?
| Kidney Diseases | 1 | 2014 | 439 | 0.020 |
Why?
| Gestational Age | 1 | 1992 | 765 | 0.020 |
Why?
| Immunoglobulin Joining Region | 1 | 1988 | 10 | 0.020 |
Why?
| Leukemia, Lymphoid | 2 | 2006 | 27 | 0.020 |
Why?
| Homeodomain Proteins | 1 | 2012 | 468 | 0.020 |
Why?
| Nedd4 Ubiquitin Protein Ligases | 1 | 2008 | 13 | 0.020 |
Why?
| Eosinophils | 2 | 2004 | 282 | 0.020 |
Why?
| Homozygote | 1 | 1989 | 190 | 0.020 |
Why?
| Endosomal Sorting Complexes Required for Transport | 1 | 2008 | 36 | 0.020 |
Why?
| Inhibitor of Apoptosis Proteins | 1 | 2008 | 44 | 0.020 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 1988 | 27 | 0.020 |
Why?
| Shock, Septic | 1 | 1990 | 187 | 0.020 |
Why?
| Animals, Newborn | 2 | 1988 | 806 | 0.020 |
Why?
| Heterozygote | 1 | 1989 | 262 | 0.020 |
Why?
| Glutamic Acid | 1 | 2010 | 224 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2008 | 139 | 0.020 |
Why?
| Immune Sera | 2 | 2005 | 82 | 0.020 |
Why?
| Caspase Inhibitors | 1 | 2008 | 82 | 0.020 |
Why?
| Nitrobenzenes | 3 | 1976 | 13 | 0.020 |
Why?
| Microspheres | 1 | 1988 | 130 | 0.020 |
Why?
| Immunoblotting | 1 | 2008 | 307 | 0.020 |
Why?
| Mice, Congenic | 1 | 2007 | 23 | 0.020 |
Why?
| Leukocyte Count | 1 | 1988 | 305 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 116 | 0.020 |
Why?
| Protease Inhibitors | 1 | 2008 | 102 | 0.020 |
Why?
| Epithelial Cells | 1 | 1993 | 963 | 0.020 |
Why?
| Antigens, CD1 | 1 | 2007 | 60 | 0.020 |
Why?
| Biological Transport | 2 | 1999 | 382 | 0.020 |
Why?
| Weight Loss | 1 | 1992 | 655 | 0.020 |
Why?
| Proto-Oncogene Proteins c-jun | 1 | 2006 | 46 | 0.020 |
Why?
| Cytoplasm | 2 | 2004 | 269 | 0.020 |
Why?
| Immunoglobulin gamma-Chains | 1 | 1986 | 2 | 0.020 |
Why?
| Antibodies, Antinuclear | 1 | 2006 | 55 | 0.020 |
Why?
| Antigens, T-Independent | 2 | 1983 | 4 | 0.020 |
Why?
| Proteinuria | 1 | 2006 | 99 | 0.020 |
Why?
| Glass | 1 | 1986 | 44 | 0.020 |
Why?
| Liver | 2 | 1992 | 1816 | 0.020 |
Why?
| Proteins | 2 | 1982 | 938 | 0.020 |
Why?
| Kidney Glomerulus | 1 | 2006 | 133 | 0.020 |
Why?
| Mast-Cell Sarcoma | 1 | 1985 | 4 | 0.020 |
Why?
| Prevalence | 1 | 2012 | 2326 | 0.020 |
Why?
| Transformation, Genetic | 1 | 1985 | 15 | 0.020 |
Why?
| Body Weight | 1 | 1990 | 934 | 0.020 |
Why?
| Cricetinae | 3 | 1994 | 262 | 0.020 |
Why?
| Liver Transplantation | 1 | 1992 | 847 | 0.020 |
Why?
| Stereoisomerism | 1 | 2005 | 93 | 0.020 |
Why?
| Injections, Subcutaneous | 1 | 2005 | 138 | 0.020 |
Why?
| Freund's Adjuvant | 1 | 2004 | 17 | 0.020 |
Why?
| Rosette Formation | 2 | 1980 | 16 | 0.020 |
Why?
| Rats, Inbred Strains | 1 | 1984 | 394 | 0.020 |
Why?
| Isoelectric Point | 1 | 1984 | 23 | 0.020 |
Why?
| Genetic Markers | 1 | 1985 | 348 | 0.020 |
Why?
| Isoelectric Focusing | 1 | 1983 | 38 | 0.010 |
Why?
| Gene Library | 1 | 2004 | 127 | 0.010 |
Why?
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2004 | 143 | 0.010 |
Why?
| Microtubule-Associated Proteins | 1 | 2005 | 188 | 0.010 |
Why?
| Receptors, CCR5 | 1 | 2003 | 54 | 0.010 |
Why?
| Intercellular Adhesion Molecule-1 | 1 | 2004 | 175 | 0.010 |
Why?
| Chemical Precipitation | 1 | 1983 | 38 | 0.010 |
Why?
| Birds | 1 | 1983 | 81 | 0.010 |
Why?
| Karyotyping | 1 | 1983 | 102 | 0.010 |
Why?
| Phosphates | 1 | 2004 | 167 | 0.010 |
Why?
| Rabbits | 3 | 1984 | 780 | 0.010 |
Why?
| Phosphoproteins | 1 | 2005 | 308 | 0.010 |
Why?
| Oxidopamine | 1 | 2002 | 13 | 0.010 |
Why?
| Ubiquitin C | 1 | 2001 | 3 | 0.010 |
Why?
| Sympatholytics | 1 | 2002 | 15 | 0.010 |
Why?
| Transplantation, Heterotopic | 1 | 2002 | 16 | 0.010 |
Why?
| Interleukin-5 | 1 | 1982 | 31 | 0.010 |
Why?
| DNA, Viral | 1 | 2004 | 356 | 0.010 |
Why?
| Tyrosine 3-Monooxygenase | 1 | 2002 | 70 | 0.010 |
Why?
| X Chromosome | 1 | 1981 | 47 | 0.010 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2004 | 420 | 0.010 |
Why?
| Immunoglobulin Constant Regions | 3 | 1986 | 6 | 0.010 |
Why?
| DNA Restriction Enzymes | 3 | 1986 | 53 | 0.010 |
Why?
| Thymectomy | 3 | 1975 | 15 | 0.010 |
Why?
| Methamphetamine | 1 | 2002 | 51 | 0.010 |
Why?
| Organ Specificity | 1 | 2001 | 278 | 0.010 |
Why?
| Genes, Reporter | 1 | 2001 | 270 | 0.010 |
Why?
| Chromatography, Gel | 2 | 1983 | 133 | 0.010 |
Why?
| Sequence Analysis, DNA | 1 | 2004 | 755 | 0.010 |
Why?
| Lyme Disease Vaccines | 1 | 2000 | 3 | 0.010 |
Why?
| Cell Cycle Proteins | 1 | 2005 | 565 | 0.010 |
Why?
| Biopolymers | 1 | 2000 | 26 | 0.010 |
Why?
| Corpus Striatum | 1 | 2002 | 127 | 0.010 |
Why?
| Lyme Disease | 1 | 2000 | 32 | 0.010 |
Why?
| Bacterial Vaccines | 1 | 2000 | 60 | 0.010 |
Why?
| HLA-DRB1 Chains | 1 | 2000 | 97 | 0.010 |
Why?
| Bacterial Outer Membrane Proteins | 1 | 2000 | 58 | 0.010 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 1999 | 12 | 0.010 |
Why?
| Genes, Dominant | 1 | 1999 | 96 | 0.010 |
Why?
| Staining and Labeling | 1 | 1980 | 146 | 0.010 |
Why?
| Androstadienes | 1 | 1999 | 94 | 0.010 |
Why?
| Immunization, Secondary | 1 | 1999 | 85 | 0.010 |
Why?
| Dopamine | 1 | 2002 | 249 | 0.010 |
Why?
| Public Policy | 1 | 1999 | 62 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 154 | 0.010 |
Why?
| Half-Life | 2 | 1977 | 147 | 0.010 |
Why?
| Computer Simulation | 1 | 2003 | 922 | 0.010 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 173 | 0.010 |
Why?
| p38 Mitogen-Activated Protein Kinases | 1 | 1999 | 285 | 0.010 |
Why?
| Asparagine | 1 | 1998 | 30 | 0.010 |
Why?
| Cartilage | 1 | 2000 | 183 | 0.010 |
Why?
| Polysaccharides, Bacterial | 2 | 1975 | 69 | 0.010 |
Why?
| Mitogen-Activated Protein Kinases | 1 | 1999 | 298 | 0.010 |
Why?
| Histocompatibility | 1 | 1977 | 27 | 0.010 |
Why?
| Codon | 1 | 1998 | 89 | 0.010 |
Why?
| Microscopy, Fluorescence | 1 | 1999 | 412 | 0.010 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 1999 | 341 | 0.010 |
Why?
| Collagen | 1 | 2000 | 433 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2002 | 1691 | 0.010 |
Why?
| Dimerization | 1 | 1997 | 183 | 0.010 |
Why?
| Warfarin | 1 | 1978 | 139 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2002 | 2478 | 0.010 |
Why?
| Antigen-Antibody Complex | 2 | 1987 | 90 | 0.010 |
Why?
| HSP70 Heat-Shock Proteins | 1 | 1996 | 74 | 0.010 |
Why?
| Research | 1 | 1999 | 411 | 0.010 |
Why?
| Radiation Effects | 1 | 1975 | 4 | 0.010 |
Why?
| Enzyme Inhibitors | 1 | 1999 | 827 | 0.010 |
Why?
| Absorption | 1 | 1975 | 56 | 0.010 |
Why?
| Mollusca | 1 | 1975 | 6 | 0.010 |
Why?
| Surface Properties | 1 | 1976 | 397 | 0.010 |
Why?
| Trachea | 1 | 1997 | 226 | 0.010 |
Why?
| Biological Transport, Active | 1 | 1994 | 73 | 0.010 |
Why?
| Endopeptidases | 1 | 1994 | 73 | 0.010 |
Why?
| Hemoglobins | 1 | 1996 | 326 | 0.010 |
Why?
| Golgi Apparatus | 1 | 1994 | 91 | 0.010 |
Why?
| Umbilical Cord | 1 | 1994 | 84 | 0.010 |
Why?
| Neurons | 1 | 2002 | 1345 | 0.010 |
Why?
| Immunologic Techniques | 2 | 1983 | 40 | 0.010 |
Why?
| Antibodies, Anti-Idiotypic | 2 | 1983 | 56 | 0.010 |
Why?
| Macaca mulatta | 1 | 1993 | 153 | 0.010 |
Why?
| Pedigree | 1 | 1994 | 485 | 0.010 |
Why?
| Zinc | 1 | 1995 | 262 | 0.010 |
Why?
| Microsomes | 1 | 1992 | 24 | 0.010 |
Why?
| Drug Synergism | 2 | 1983 | 339 | 0.010 |
Why?
| Genetic Variation | 2 | 1990 | 926 | 0.010 |
Why?
| Models, Structural | 1 | 1991 | 38 | 0.010 |
Why?
| Methionine | 1 | 1992 | 145 | 0.010 |
Why?
| 6-Ketoprostaglandin F1 alpha | 1 | 1991 | 21 | 0.010 |
Why?
| Calcimycin | 1 | 1991 | 57 | 0.010 |
Why?
| Carbohydrates | 1 | 1991 | 59 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1997 | 907 | 0.010 |
Why?
| Arthritis | 1 | 1991 | 112 | 0.010 |
Why?
| Genes, MHC Class I | 1 | 1990 | 33 | 0.010 |
Why?
| Cricetulus | 1 | 1989 | 98 | 0.010 |
Why?
| Deoxyribonuclease HpaII | 1 | 1988 | 2 | 0.010 |
Why?
| Deoxyribonuclease BamHI | 1 | 1988 | 3 | 0.010 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 17 | 0.010 |
Why?
| Phosphorylcholine | 1 | 1988 | 18 | 0.010 |
Why?
| Reference Values | 1 | 1990 | 774 | 0.010 |
Why?
| Extracellular Space | 1 | 1989 | 127 | 0.010 |
Why?
| Cross-Linking Reagents | 1 | 1989 | 186 | 0.010 |
Why?
| Introns | 1 | 1988 | 234 | 0.000 |
Why?
| Mannose | 1 | 1987 | 21 | 0.000 |
Why?
| Bacteriophage lambda | 1 | 1988 | 81 | 0.000 |
Why?
| Hexosaminidases | 1 | 1987 | 17 | 0.000 |
Why?
| Exons | 1 | 1988 | 307 | 0.000 |
Why?
| Oligosaccharides | 1 | 1987 | 54 | 0.000 |
Why?
| Enhancer Elements, Genetic | 1 | 1988 | 152 | 0.000 |
Why?
| Pepsin A | 1 | 1986 | 18 | 0.000 |
Why?
| Vinblastine | 2 | 1976 | 68 | 0.000 |
Why?
| Hypersensitivity, Delayed | 2 | 1978 | 52 | 0.000 |
Why?
| Staphylococcal Infections | 1 | 1990 | 346 | 0.000 |
Why?
| Immunoglobulin J-Chains | 1 | 1985 | 7 | 0.000 |
Why?
| Immunoenzyme Techniques | 1 | 1985 | 195 | 0.000 |
Why?
| Genetic Code | 1 | 1985 | 20 | 0.000 |
Why?
| Immunoglobulin Light Chains | 1 | 1984 | 35 | 0.000 |
Why?
| Protein Denaturation | 1 | 1984 | 73 | 0.000 |
Why?
| Membranes, Artificial | 1 | 1984 | 70 | 0.000 |
Why?
| Albumins | 1 | 1984 | 100 | 0.000 |
Why?
| Thymus Neoplasms | 1 | 1984 | 21 | 0.000 |
Why?
| Bacteria | 1 | 1991 | 757 | 0.000 |
Why?
| Macrophage-Activating Factors | 1 | 1983 | 4 | 0.000 |
Why?
| Fixatives | 1 | 1983 | 16 | 0.000 |
Why?
| Cell-Free System | 1 | 1983 | 49 | 0.000 |
Why?
| Glutaral | 1 | 1983 | 15 | 0.000 |
Why?
| Receptors, Antigen | 1 | 1983 | 11 | 0.000 |
Why?
| Longitudinal Studies | 1 | 1990 | 2513 | 0.000 |
Why?
| Cell Nucleus | 1 | 1985 | 580 | 0.000 |
Why?
| Fetal Blood | 1 | 1983 | 272 | 0.000 |
Why?
| Pulmonary Alveoli | 1 | 1983 | 384 | 0.000 |
Why?
| Polymers | 1 | 1983 | 482 | 0.000 |
Why?
| Isoantigens | 1 | 1977 | 19 | 0.000 |
Why?
| Child | 1 | 1994 | 19129 | 0.000 |
Why?
| Skin Tests | 1 | 1975 | 135 | 0.000 |
Why?
| Immunoglobulin M | 1 | 1975 | 253 | 0.000 |
Why?
|
|
Marrack's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|